Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
Status:
Completed
Trial end date:
2000-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give HIV-infected children
and teens 1 of 4 anti-HIV drug combinations.
Decreasing HIV levels in infected patients can slow down disease progression. Further study
is needed to find out which drug combinations are most effective in doing this.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
HIV Protease Inhibitors Lamivudine Nelfinavir Nevirapine Protease Inhibitors Ritonavir Stavudine